Q1 2020 Holdings
Filed 2020-05-18 | 57 holdings | $47.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Biogen Inc(BIIB) | COM | 09062X103 | $14.5M | 45,700 | 30.2% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $14.3M | 169,784 | 29.9% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $14.2M | 337,000 | 29.7% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $2.4M | 22,300 | 5.1% |
| Ascendis Pharma AS(ASND) | Sponsored ADR | 04351P101 | $1.5M | 13,800 | 3.2% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $762.0K | 21,500 | 1.6% |
| Vertex Pharmaceuticals Inc(VRTX) | COM | 92532F100 | $18.5K | 77,822 | 0.0% |
| Gilead Sciences Inc(GILD) | COM | 375558103 | $17.7K | 237,284 | 0.0% |
| Amgen Inc(AMGN) | COM | 031162100 | $13.4K | 66,000 | 0.0% |
| PTC Therapuetics COM(PTCT) | COM | 69366J200 | $12.0K | 269,000 | 0.0% |
| Horizon Therapeutics PUB LTD | SHS | G46188101 | $11.7K | 394,000 | 0.0% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $9.3K | 107,300 | 0.0% |
| Chemocentryx Inc(CCXIEUR) | COM | 16383L106 | $7.6K | 190,000 | 0.0% |
| Incyte Corp(INCY) | COM | 45337C102 | $7.3K | 99,500 | 0.0% |
| Zogenix Inc | COM | 98978L204 | $7.0K | 281,797 | 0.0% |
| Alexion Pharmaceuticals Inc(ALXN) | COM | 015351109 | $6.6K | 73,641 | 0.0% |
| Seattle Genetics Inc | COM | 812578102 | $6.6K | 56,900 | 0.0% |
| Merck & Co Inc(MRK) | COM | 58933Y105 | $6.4K | 83,200 | 0.0% |
| Halozyme Therapeutics Inc(HALO) | COM | 40637H109 | $5.5K | 307,633 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $3.4K | 43,900 | 0.0% |
| Lilly ELI & Co(LLY) | COM | 532457108 | $2.8K | 20,000 | 0.0% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $2.7K | 28,100 | 0.0% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $2.5K | 53,781 | 0.0% |
| Enanta Pharmaceuticals Inc(ENTA) | COM | 29251M106 | $2.4K | 46,500 | 0.0% |
| Exelixis Inc(EXEL) | COM | 30161Q104 | $1.8K | 103,534 | 0.0% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $1.7K | 227,433 | 0.0% |
| Acceleron Pharma Inc(XLRN) | COM | 00434H108 | $1.6K | 18,000 | 0.0% |
| Turning Point Therapeutics I | COM | 90041T108 | $1.5K | 35,000 | 0.0% |
| Sutro Biopharma Inc | COM | 869367102 | $1.4K | 139,331 | 0.0% |
| Principia Biopharma Inc(PRNB) | COM | 74257L108 | $1.4K | 23,100 | 0.0% |
| Uniqure NV(QURE) | SHS | N90064101 | $1.3K | 27,500 | 0.0% |
| Amarin Corp Plc | SPONS ADR NEW | 023111206 | $1.3K | 320,000 | 0.0% |
| Nektar Therapeutics(NKTREUR) | COM | 640268108 | $1.2K | 67,000 | 0.0% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $1.1K | 37,600 | 0.0% |
| Immunomedics Inc(IMMU) | COM | 452907108 | $970 | 72,000 | 0.0% |
| Millendo Therapeutics Inc | COM | 60040X103 | $939 | 177,825 | 0.0% |
| Crispr Therapeutics AG(CRSP) | NAMEN AKT | H17182108 | $930 | 22,000 | 0.0% |
| GW Pharmaceuticals Plc | ADS | 36197T103 | $893 | 10,200 | 0.0% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $873 | 94,600 | 0.0% |
| Alkermes PLC(ALKS) | SHS | G01767105 | $749 | 52,000 | 0.0% |
| Myokardia Inc | COM | 62857M105 | $743 | 15,859 | 0.0% |
| Momenta Pharmaceuticals Inc(MNTA) | COM | 60877T100 | $734 | 27,000 | 0.0% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $700 | 12,000 | 0.0% |
| Deciphera Pharmaceuticals Inc(DCPHEUR) | COM | 24344T101 | $697 | 17,000 | 0.0% |
| Allakos Inc(ALLKGUSD) | COM | 01671P100 | $692 | 15,700 | 0.0% |
| Arena Pharmaceuticals Inc(ARNAEUR) | COM | 040047607 | $690 | 16,500 | 0.0% |
| FibroGen Inc(FGENEUR) | COM | 31572Q808 | $684 | 19,700 | 0.0% |
| Tricida Inc(1T7) | COM | 89610F101 | $635 | 29,000 | 0.0% |
| Exact Sciences Corp(EXAS) | COM | 30063P105 | $619 | 10,700 | 0.0% |
| Insmed Inc(INSM) | COM | 457669307 | $537 | 33,600 | 0.0% |